Video: Banks will deliver strong earnings due to ‘credit euphoria,’ top analyst Mike Mayo predicts (CNBC)
Shares of Johnson & Johnson slid 1.60% to $157.69 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.24% to 4,350.65 and Dow Jones Industrial Average falling 0.34% to 34,378.34. This was the stock’s third consecutive day of losses. Johnson & Johnson closed $22.23 below its 52-week high ($179.92), which the company reached on August 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. fell 0.89% to $381.51, Merck & Co. Inc. fell 0.43% to $79.59, and Pfizer Inc. fell 0.50% to $41.85. Trading volume (6.7 M) eclipsed its 50-day average volume of 5.7 M.